The Burden of Skin and Subcutaneous Diseases in North Africa and the Middle East (NAME) From 1990 to 2021
International Journal of Dermatology · 2025
DOI: 10.1111/ijd.17953 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Ghida El Banna und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Skin Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Skin diseases contribute significantly to morbidity worldwide, yet their burden in North Africa and the Middle East (NAME) remains poorly understood. This study aims to assess the burden of skin diseases in NAME from 1990 to 2021.
Methods
Using data from the Global Burden of Disease (GBD) study, we analyzed disability‐adjusted life‐years (DALYs) and age‐adjusted prevalence, incidence, and mortality rates of 23 skin conditions across 21 NAME countries from 1990 to 2021.
Results
In 2021, skin and subcutaneous diseases ranked as the 22nd leading cause of morbidity and mortality in NAME, with a 0.06% increase in DALYs since 1990 (95% confidence interval [CI]: 0.05%–0.08%). The most prevalent skin conditions (age‐adjusted per 100,000) were other skin and subcutaneous diseases (6788.41), fungal skin diseases (3311.44), acne vulgaris (3102.51), atopic dermatitis (1374.93), viral skin diseases (1257.88), scabies (1009.72), contact dermatitis (998.89), pruritus (980.93), urticaria (936.13), and cutaneous leishmaniasis (642.73). Qatar experienced the largest DALYs increase in skin disease (0.12%; 95% CI: 0.07%–0.18%). Notable geographic variations included increased DALYs for acne vulgaris, psoriasis, and viral skin diseases across all countries; a rise in cutaneous leishmaniasis in Afghanistan, Syria, and Morocco; and a decline in measles, varicella‐herpes zoster, and leprosy (except in Iran).
Conclusion
Skin diseases impose a significant and evolving burden in NAME, with notable temporal and geographic variations. Further research is needed to better understand disease epidemiology and guide future interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon.
ORCID-Profile: Ghida El Banna
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
El Banna, G., Braun, N., Baker, N. M., Peacker, B. L., Ma, K. S., Kibbi, A. G., & Chen, S. T. (2025). The Burden of Skin and Subcutaneous Diseases in North Africa and the Middle East (NAME) From 1990 to 2021. International Journal of Dermatology. https://doi.org/10.1111/ijd.17953
Vancouver
El Banna G, Braun N, Baker NM, Peacker BL, Ma KS, Kibbi AG, et al. The Burden of Skin and Subcutaneous Diseases in North Africa and the Middle East (NAME) From 1990 to 2021. International Journal of Dermatology. 2025. doi:10.1111/ijd.17953
BibTeX
@article{ElBanna2025,
author = {El Banna, Ghida and Braun, Natalie and Baker, Natalie M and Peacker, Bryan L and Ma, Kevin Sheng-Kai and Kibbi, Abdul Ghani and Chen, Steven T},
title = {The Burden of Skin and Subcutaneous Diseases in North Africa and the Middle East (NAME) From 1990 to 2021},
journal = {International Journal of Dermatology},
year = {2025},
doi = {10.1111/ijd.17953}
}
EUVIMED